Precision BioSciences’ (DTIL) “Buy” Rating Reiterated at HC Wainwright
HC Wainwright restated their buy rating on shares of Precision BioSciences (NASDAQ:DTIL – Free Report) in a report published on Wednesday morning,Benzinga reports. The firm currently has a $60.00 target price on the stock. HC Wainwright also issued estimates for Precision BioSciences’ Q2 2025 earnings at ($0.09) EPS, Q3 2025 earnings at ($0.38) EPS and […]
